MEL ROTHBERG
Compensation Chairman
Mel Rothberg currently serves as Chairman of BioFlorida's Southeast Chapter. Over the past 30 years, he has made significant contributions to the development of the South Florida bioscience industry. He has a wide range of experience with medical device and biopharmaceutical companies including presently serving as Chairman and Chief Executive Officer of Advanced Processing & Imaging, Chief Executive Officer of Dharma Biomedical and Chief Executive Officer of Rothberg Associates, Inc.

He is a past member of the Board of Directors of Lotus Pharmaceuticals, Inc. and previous Executive Vice President, Operations of Viragen, Inc., Director of Viragen International, Inc. and Viranative AB where he was responsible for manufacturing, regulatory, business development, marketing and sales of Multiferon. Prior to Viragen, he was Vice President of Manufacturing and Business Development for Althin Medical, a Swedish publicly-held company. Rothberg also had multiple responsibilities with Dow Chemical and was Managing Director of Cordis Dow's European manufacturing operations in the Netherlands.

Rothberg is active in numerous professional associations including the American Institute of Chemical Engineers, North American Membrane Society, Association of University Technology Managers and is a member of the BioFlorida Board of Directors, iCoast Board of Directors, Florida International University Biomedical Engineering Advisory Board, Nova Southeastern University School of Dentistry Board of Councilors and a member of the Broward County Workforce Development Board. He is a graduate of Vanderbilt University with a Chemical Engineering degree and has a Master of Business Administration degree from Nova Southeastern University.